Ipca Laboratories Limited (BOM:524494)
1,497.30
+28.00 (1.91%)
At close: Feb 20, 2025
Ipca Laboratories Statistics
Total Valuation
BOM:524494 has a market cap or net worth of INR 366.59 billion. The enterprise value is 383.75 billion.
Market Cap | 366.59B |
Enterprise Value | 383.75B |
Important Dates
The last earnings date was Thursday, February 13, 2025.
Earnings Date | Feb 13, 2025 |
Ex-Dividend Date | Nov 27, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.05% |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 139.40M |
Valuation Ratios
The trailing PE ratio is 50.26.
PE Ratio | 50.26 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 5.67 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 52.61 |
EV / Sales | 4.40 |
EV / EBITDA | 23.90 |
EV / EBIT | 32.28 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.15 |
Debt / EBITDA | 0.75 |
Debt / FCF | n/a |
Interest Coverage | 12.97 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 7.89% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 5.03M |
Profits Per Employee | 420,796 |
Employee Count | 17,335 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.14% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +21.14% |
50-Day Moving Average | 1,546.87 |
200-Day Moving Average | 1,427.57 |
Relative Strength Index (RSI) | 43.86 |
Average Volume (20 Days) | 10,735 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524494 had revenue of INR 87.27 billion and earned 7.29 billion in profits. Earnings per share was 28.74.
Revenue | 87.27B |
Gross Profit | 56.99B |
Operating Income | 11.91B |
Pretax Income | 10.78B |
Net Income | 7.29B |
EBITDA | 15.91B |
EBIT | 11.91B |
Earnings Per Share (EPS) | 28.74 |
Balance Sheet
The company has 9.03 billion in cash and 12.02 billion in debt, giving a net cash position of -2.99 billion.
Cash & Cash Equivalents | 9.03B |
Total Debt | 12.02B |
Net Cash | -2.99B |
Net Cash Per Share | n/a |
Equity (Book Value) | 81.18B |
Book Value Per Share | 264.24 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 65.30%, with operating and profit margins of 13.65% and 8.36%.
Gross Margin | 65.30% |
Operating Margin | 13.65% |
Pretax Margin | 12.35% |
Profit Margin | 8.36% |
EBITDA Margin | 18.24% |
EBIT Margin | 13.65% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.27%.
Dividend Per Share | 4.00 |
Dividend Yield | 0.27% |
Dividend Growth (YoY) | 100.00% |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.05% |
Shareholder Yield | 0.22% |
Earnings Yield | 1.99% |
FCF Yield | n/a |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
Last Split Date | Jan 10, 2022 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |